болезнь Вильсона-Коноваловаболезнь Гошегликогенозынаследственные заболевания1.Болезни печени и желчевыводящих путей. Рук. для врачей. Под ред. В.Т.Ивашкина. М.:ООО "Издат. дом "М-Вести", 2002.2.Bianchi L. Glycogen storage disease 1 and hepatocellular tumors. Eur J Pediatr 1993; 152: 63.3.Ghishan F.K. Alpha1-antitrypsin deficiency. In: Zakim D, Boyer T.D. Hepatology: A Text book of Liver Disease. 1996; 1565-73.4.Ghishan F.K. Inborn errors of metabolism that lead to permanent liver injury In: Zakim D, Boyer T.D. Hepatology: A Text book of Liver Disease. 1996; 1574-629.5.Mowat A.P. Orthotopic liver transplantation in liver - based metabolic disorders. Eur J Pediatr 1992; 22: 32-8.6.Propst T, Propst A, Dietze O et al. Prevalence of hepatocellular carcinoma in a1-antitrypsin deficiency. J hepatol 1994; 21: 1006.7.Schilsky M.L. Wilson disease: genetic basis of copper toxicity and natural history. Semin Liver Dis 1996; 16: 83-95.8.Schoen R.E, Sternlieb I. Clinical aspects of Wilsonўs disease. Am J Gastroenterol 1990; 85: 1456.9.Socol R.J. Copper storage diseases. In Kaplowitz N. Liver and Biliary Diseases. 1996; 363-77.10.Steindl P, Ferenci P, Dienes H.P et al. Wilson’s disease in patient presenting with liver disease: diagnostic challenge. Gastroenterology 1997; 113: 212-8.11.Suchy F.J, Shneider B.L. Metabolic liver diseases of childhood. In Kaplowitz N. Liver and Biliary Diseases. 1996; 511-34.12.Tanner M.S, Taylor C.J. Liver disease in cystic fibrosis. Arch Dis Child 1995; 72: 281.13.Welsh M.J, Smith A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cel l. 1993; 73: 1251.14.Zucker S.D, Gollan J.L. Wilsonўs disease and hepatic copper toxicosis. In: Zakim D, Boyer T.D. Hepatology: A Text book of Liver Disease. 1996; 1405-39.